Human immunodeficiency virus (HIV) expression and replication are under tight regulatory control. We demonstrate that 1,25-dihydroxycholecalciferol [1,25-(OH)2D3] enhances the replication of monocyte-and lymphocyte-tropic strains of HIV-1 up to 10,000-fold in monocyte cell lines, peripheral blood monocytes, and unfractionated peripheral blood mononuclear cells. 1,25(OH)2D3 is therefore one of the most potent regulators of HIV-1 replication described to date. Precursors of 1,25(OH)2D3 enhance HIV-1 replication in proportion to their affinity for the 1,25(OH)2D3 intracellular receptor, suggesting that 1,25(OH)2D3 influences HIV-1 replication by mechanisms involving this receptor. These studies may have important implications for the design of effective therapy of HIV-1 infection.
virus to other cell types, passage of virus between various organ systems within the body (e.g., across the blood-brain or blood-retina barrier), and eventual progression to HIVrelated illness. Understanding the factors that regulate HIV-1 replication in monocytes could lead to new approaches capable of modulating disease expression in those tissues harboring HIV-1-infected monocyte/macrophages.
Expression of HIV in monocytes is under the control of several cell regulatory factors (2, 3). 1,25-Dihydroxycholecalciferol [1,25(0H)2D3], the biologically active form of vitamin D, has multiple effects on cellular differentiation and function, including regulation of surface differentiation antigens, oncogene expression, cytokine production, protein kinase C activity, phagocytosis, and heat-shock protein production (reviewed in refs. 4 and 5). Since HIV-1 replication is related to the cell surface expression of CD4 antigen (6, 7) and the state of activation of cells (8, 9) , we hypothesized that 1,25(OH)2D3 might affect HIV-1 replication. To test this hypothesis, we evaluated HIV-1 replication in a monocytoid cell line, peripheral blood monocytes, and unfractionated peripheral blood mononuclear cells (PBMC) 
MATERIALS AND METHODS
Cell Lines and Virus Stocks. BT4A3.5 (A3.5) cells are a clone of monocytic cells that were isolated from human bone cell cultures (these cells were originally isolated and characterized by S. R. Goldring, E. P. Amento, B. Jahn, A. Duran, and S.M.K., unpublished). The cells are CD4', HLA-DR', CD15' (Leu-M1), and CD3-, they produce interleukin 1 after stimulation with endotoxin, and they are susceptible to infection with lymphocyte-and monocyte-tropic strains of HIV-1. Peripheral blood monocytes were separated from PBMC of HIV-1 seronegative donors by counterflow centrifugation (elutriation) in a Beckman JE-5.0 elutriator chamber and rotor. This method allows for the separation of large numbers of minimally activated, highly purified monocytes (10 (11)]. An aliquot from each sample was assayed for cell viability by trypan blue exclusion. Fresh medium was added every 3-4 days with the appropriate concentration of 1,25(OH)2D3. For the experiment depicted in Fig. 2B and others (including those with peripheral blood monocytes), HIV-1 (moi = 5 x l0-3 TCID50 per cell) and 1,25(OH)2D3 were added simultaneously to the cells.
Cocultures of PBMC. PBMC were isolated from HIV-1 seropositive individuals by Ficoll/Hypaque density centrifugation of heparinized peripheral blood (<10 units/ml). Cocultures were performed with PBMC from HIV-1 seronegative donors prestimulated for 3-4 days with phytohemagglutinin P (Difco) and interleukin 2 (Pharmacia) as described (12) . Four parallel cocultures were performed: these cocultures contained 1,25(OH)2D3 (24 nM (24) . HIV-1 gpl20
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induces an increase in concentration of intracellular free calcium that is associated with toxicity to rodent retinal ganglion cells and hippocampal neurons; these effects are abrogated by the calcium channel blocker nimodipine (25) . Diphenylhydantoin inhibits the HIV-induced increase in concentration of intracellular calcium and potentiates the antiretroviral activity of zidovudine (AZT) in some cell lines (26) .
Steroid hormones influence transactivation of promoter regions in other retroviral systems. The mouse mammary tumor virus long terminal repeat (LTR) contains a cis-acting target [glucocorticoid response element (GRE)] for the glucocorticoid-receptor complex (27, 28) . This DNA-protein/ receptor interaction increases transcription from linked initiation sites relatively independently of the orientation of the GRE or its distance from heterologous promoters (27) . Cellular transcription factors (the mouse homolog of NF-1, F-i) may also be important in this interaction (29, 30 
